Status of Class III Antiarrhythmic Drugs: Amiodarone, Bretylium and Sotalol
Author:
Horowitz Leonard N.
Reference52 articles.
1. International Congress and Symposium Series;EMV Williams,1979
2. Rosenbaum MB, Chiale PA, Ryba D, Elizari MV: Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol 34: 215–23, 1974
3. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Pryzbylski J, Levi RJ, Lazzari JO, Elizari MV: Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 38:934–44, 1976
4. Singh BN, Vaughan Williams EM: Effects of amiodarone: A very antianginal drug on cardiac muscle. Br J Pharmacol 39:657–659, 1970
5. Saksena S, Rothbart ST, Cappello G: Chronic effects of amiodarone in patients with refractory ventricular tachycardia. Int J Cardiol 3:339–351, 1983